FluoroPharma Medical Income After Taxes 2010-2016 | FPMI

FluoroPharma Medical income after taxes from 2010 to 2016. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

FluoroPharma Medical Income After Taxes 2010-2016 | FPMI

FluoroPharma Medical income after taxes from 2010 to 2016. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$195.6B
Stryker (SYK)$137.3B
Boston Scientific (BSX)$122.7B
Medtronic (MDT)$114.6B
EssilorLuxottica (ESLOY)$108.8B
Haleon (HLN)$48.7B
Lonza Group Ag (LZAGY)$46B
ResMed (RMD)$35.1B
Koninklijke Philips (PHG)$30.8B
Terumo (TRUMY)$28.5B
Zimmer Biomet Holdings (ZBH)$22B
Baxter (BAX)$19.9B
Insulet (PODD)$16.3B
Smith & Nephew SNATS (SNN)$13.6B
Bio-Rad Laboratories (BIO)$9.2B
Demant (WILYY)$8.7B
BellRing Brands (BRBR)$7.9B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.3B
Haemonetics (HAE)$4.1B
TG Therapeutics (TGTX)$3.7B
Neogen (NEOG)$3.6B
Prestige Consumer Healthcare (PBH)$3.5B
GN Store Nord (GNNDY)$3.5B
Perrigo (PRGO)$3.5B
Envista Holdings (NVST)$3.4B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Green Thumb Industries (GTBIF)$2.2B
Maravai LifeSciences Holdings (MRVI)$2.1B